Norway· NO-ID_60FB6F64-3FE2-4000-A2EC-2582F7927155
Dovato
A lamivudine and dolutegravir product containing lamivudine + dolutegravir, registered in Norway by ViiV Healthcare BV (1). The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Lamivudine and dolutegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR25 (lamivudine and dolutegravir), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Lamivudine and dolutegravir · ATC J05AR25
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Lamivudine + Dolutegravir
- Manufacturer
- ViiV Healthcare BV (1)
- Country
- Norway (NO)
- ATC code
- J05AR25
- ATC class
- Lamivudine and dolutegravir
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_60FB6F64-3FE2-4000-A2EC-2582F7927155
- no_varenummer57853730NOK 9060.7
- gtin5054626151269
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lamivudine and dolutegravir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDOVATOViiV Healthcare BV, Amersfoort
- FinlandDovatoOrifarm Oy
- SwitzerlandDovato
- SpainDOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULAViiv Healthcare B.V.
- IcelandDOVATOViiV Healthcare BV
- NetherlandsDovato 50 mg/300 mg filmomhulde tablettenViiV healthcare B.V.
- PolandDovatoViiV Healthcare BV
- SwedenDOVATO 50 mg/300 mg Filmdragerad tablettViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Dovato
- Liechtenstein · Dovato
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e9d790a6-53eb-4a82-8e3c-c3ca94bb7eb8 GET /v1/drugs/e9d790a6-53eb-4a82-8e3c-c3ca94bb7eb8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Lamivudin og dolutegravir",
"merkevare_id": "ID_60FB6F64-3FE2-4000-A2EC-2582F7927155",
"name_form_strength": "Dovato tab 50 mg/300 mg",
"prescription_group": "C"
}See everything about lamivudine and dolutegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.